title: Using oral agents to manage gestational diabetes: what have we learned?
abstract: Insulin has been the mainstay of treatment of diabetes during pregnancy for decades. Although glyburide and metformin are classified as category B during pregnancy, recent research has suggested that these oral agents alone or in conjunction with insulin may be safe for the treatment of gestational diabetes (GDM). This paper summarizes the data on the use of glyburide and metformin for treatment of GDM.
authors.affiliation: University of Michigan, 24 Frank Lloyd Wright Drive, Ann Arbor, MI, 48105, USA, eliosbor@med.umich.edu.
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Buschur
authors.forename: Florence
authors.initials: F
authors.lastname: Brown
authors.forename: Jennifer
authors.initials: J
authors.lastname: Wyckoff
mesh_terms: D020909:Acarbose / Q000008:administration & dosage; D000284:Administration, Oral; D001724:Birth Weight; D016640:Diabetes, Gestational / Q000188:drug therapy*; D005260:Female; D005905:Glyburide / Q000008:administration & dosage*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007231:Infant, Newborn; D008687:Metformin / Q000008:administration & dosage*; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D016896:Treatment Outcome
chemical_list: D007004:Hypoglycemic Agents; D008687:Metformin; D005905:Glyburide; D020909:Acarbose